✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Lyka Labs Ltd.

LYKALABS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹356 Cr.
P/E
47.45

Lyka Labs Ltd.

  • Lyka Labs
  • Zim Laboratories
  • Medico Remedies
FAQs on Lyka Labs Ltd. Shareprice

Lyka Labs has given better returns compared to its competitors.
Lyka Labs has grown at ~-5.78% over the last 2yrs while peers have grown at a median rate of -7.71%

Lyka Labs is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Lyka Labs is 48.28, while 3 year average PE is 71.66.
Also latest EV/EBITDA of Lyka Labs is 22.31 while 3yr average is 20.02.

View FAQ's On Business
Growth Table
  • Lyka Labs Ltd.
  • Zim Laboratories
  • Medico Remedies
Balance Sheet
  • Lyka Labs Ltd.
  • Zim Laboratories
  • Medico Remedies
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Lyka Labs Ltd.
  • Zim Laboratories
  • Medico Remedies
Cash Flow
  • Lyka Labs Ltd.
  • Zim Laboratories
  • Medico Remedies
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Lyka Labs Ltd.
  • Zim Laboratories
  • Medico Remedies
Quarterly Results
  • Lyka Labs Ltd.
  • Zim Laboratories
  • Medico Remedies
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Lyka Labs Ltd. Financials

Balance sheet of Lyka Labs is strong.
It shouldn't have solvency or liquidity issues.

The debt of Lyka Labs is decreasing.
Latest debt of Lyka Labs is ₹35.38 Crs as of Mar-25.
This is less than Mar-24 when it was ₹44.88 Crs.

The profit is oscillating.
The profit of Lyka Labs is ₹7.64 Crs for TTM, ₹8.01 Crs for Mar 2025 and -₹2.49 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lyka Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech